文献速递慢性静脉疾病

非复合型1%聚多卡醇静脉内微泡沫与热消融治疗慢性静脉功能不全的活体网络荟萃分析更新

Update of a Living Network Meta-Analysis Comparing Non-compounded Polidocanol 1% Endovenous Microfoam (Varithena) Ablation versus Endovenous Thermal Ablation in Chronic Venous Insufficiency
RSS 订阅 · PubMed · J Vasc Surg Venous Lymphat Disord · 2026-10-26

本活体网络荟萃分析每季度检索至2026年3月,新增11项研究,共纳入24项研究、235,413例患者,比较1%聚多卡醇静脉内微泡沫与静脉内热消融治疗下肢躯干静脉功能不全的疗效与安全性。结果显示两组在静脉闭合、深静脉血栓风险及疾病特异性生活质量或症状改善方面均无统计学显著差异。

要点

  • 聚多卡醇微泡沫与热消融在静脉闭合上无统计学差异(OR 0.71,95%CI 0.42–1.21)。
  • 聚多卡醇微泡沫未增加深静脉血栓风险(OR 0.83,95%CI 0.29–2.43)。
  • 生活质量或症状改善评分两组无显著差异(Hedges' g 0.04,95%CI -0.16–0.25)。

核心结论

  • 更新后的活体网络荟萃分析强化了原结论:1%聚多卡醇静脉内微泡沫与静脉内热消融在静脉闭合、深静脉血栓风险及疾病特异性生活质量或症状改善方面无统计学显著差异。

研究设计与样本

  • 系统评价按照预设方案每季度检索至2026年3月,未改变选择标准。
  • 更新检索新增507条引文和11项合格研究,共纳入24项研究、235,413例患者。
  • 静脉闭合、深静脉血栓和溃疡愈合以比值比(95%CI)汇总,疾病特异性生活质量或症状改善量表以Hedges' g标准化均数差汇总。

主要发现

  • 聚多卡醇静脉内微泡沫与静脉内热消融在静脉闭合方面无统计学差异(OR 0.71,95%CI 0.42–1.21)。
  • 最长随访(平均28个月,范围12–72个月)的敏感性分析结果相似(OR 0.71,95%CI 0.45–1.11)。
  • 聚多卡醇静脉内微泡沫相比热消融未显示深静脉血栓风险增加(OR 0.83,95%CI 0.29–2.43)。
  • 治疗后疾病特异性生活质量或静脉功能不全症状改善在两组间无统计学显著差异(Hedges' g 0.04,95%CI -0.16–0.25),但网络未完全连接。
  • 溃疡愈合数据有限,探索性分析未发现统计学显著差异。

临床怎么用

  • 对于下肢躯干静脉功能不全的成人患者,1%聚多卡醇静脉内微泡沫可作为静脉内热消融之外的替代选择,两者在静脉闭合、深静脉血栓风险及症状改善方面无显著差异。

局限性

  • 生活质量或症状改善的网络未完全连接。
  • 溃疡愈合数据有限,仅作探索性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

J Vasc Surg Venous Lymphat Disord . 2026 Oct 26:102648. doi: 10.1016/j.jvsv.2026.102648. Online ahead of print. ABSTRACT OBJECTIVE: We previously published a network meta-analysis showing no statistically significant difference between commercially manufactured polidocanol 1% endovenous microfoam and endovenous thermal ablation for vein closure or deep vein thrombosis, when polidocanol endovenous microfoam was distinguished from physician-compounded foam. This living network meta-analysis updates the previous analysis comparing the effectiveness and safety of polidocanol endovenous microfoam ablation versus endovenous thermal ablation for the primary treatment of adult patients with venous insufficiency caused by lower-extremity truncal vein incompetence. METHODS: Systematic review searches following the prespecified protocol were conducted quarterly through March 2026. No changes were made to selection criteria. Vein closure, deep venous thrombosis, and ulcer healing were summarized as odds ratios with 95% confidence intervals. A composite outcome of disease-specific quality of life or symptom improvement scales was summarized with Hedges' g standardized mean difference. RESULTS: The updated search yielded 507 new citations and 11 new eligible studies, for a total of 24 studies (235,413 patients). Polidocanol endovenous microfoam was not statistically different from endovenous thermal ablation for vein closure (odds ratio 0.71, 95% confidence interval 0.42 to 1.21). A sensitivity analysis at longest follow-up (mean 28 months, range 12-72 months) showed similar results (odds ratio 0.71, 95% confidence interval 0.45 to 1.11). There was no evidence of increased deep venous thrombosis risk with polidocanol endovenous microfoam versus endovenous thermal ablation (odds ratio 0.83, 95% confidence interval 0.29 to 2.43). Post-treatment improvement in disease-specific quality of life or venous insufficiency symptoms showed no statistically significant difference between polidocanol endovenous microfoam and endovenous thermal ablation (standardized mean difference [Hedges' g] 0.04, 95% confidence interval -0.16 to 0.25), though the network was not fully connected. Finally, ulcer healing data was limited, but an exploratory analysis found no evidence of a statistically significant difference. CONCLUSIONS: This living network meta-analysis update reinforced the original findings that polidocanol 1% endovenous microfoam is not statistically different from endovenous t

来源:PubMed · J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. PubMed · J Vasc Surg Venous Lymphat Disord:Update of a Living Network Meta-Analysis Comparing Non-compounded Polidocanol 1% Endovenous Microfoam (Varithena) Ablation versus Endovenous Thermal Ablation in Chronic Venous Insufficiency

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。